A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

by | Oct 20, 2025 | Clinical Trials | 0 comments

​ Conditions: Active Noninfectious Uveitis Affecting the Posterior Segment

Interventions: Drug: REGN7041

Sponsors: Regeneron Pharmaceuticals

Not yet recruiting Conditions: Active Noninfectious Uveitis Affecting the Posterior Segment
Interventions: Drug: REGN7041
Sponsors: Regeneron Pharmaceuticals
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *